BioPolicy Summit 2017: Improving Reproducibility of Research Through Digital Tools, Technologies and Laboratory Automation

16 October 2017
San Francisco, United States
 

Global Biological Standards Institute’s 3rd annual BioPolicy Summit will bring a diverse and interdisciplinary group of participants together—biologists, tech programmers, instrumentation manufacturers, the maker community, journals and funders—to explore how the newest life science research tools and technology can enhance reproducibility in preclinical research. The meeting will highlight affordable, accessible biotech solutions that democratize scientific discovery, increase efficiency and tighten quality control. It runs from 8:30 a.m. to 8:00 p.m. PST, including registration, the program, exhibits and a reception. 

The group will examine innovations that are redefining the laboratory environment and workflow characteristics at every step of the scientific process. Top scientists and tech inventors will demonstrate their latest innovations, such as affordable miniaturized robotics advancements, and new systems to gather, edit, share, improve and publish information and detailed protocols that will revolutionize the way science is done. Scientists, researchers and academicians will offer insight into organizational strategies and tools needed to capture the benefits of automation and steer discussion about how these innovations, along with traditional scientific methods and expertise, will revolutionize and ultimately advance treatments and cures. 

PROGRAM AND PRESENTERS:  At the meeting, leaders and innovators representing all stakeholders in emerging lab design and automation – scientists, designers, developers, technicians, and researchers that use the advanced equipment will facilitate and present quickly-paced sessions and guide 150 attendees through current and next generation innovations used at each phase of research design. 

Featured speakers & panelists are joining us from: Autodesk, Gates Foundation, Nature, NCATS, Riffyn, Science Exchange, Stanford University, Synthace, Transcriptic, and Umech Technologies.

The meeting steering committee includes:  Leonard P. Freedman, Ph.D., President, Global Biological Standards Institute; Nancy J. Kelley, JD/MPP, President and CEO, Nancy J. Kelley Associates; Will Canine, Co-founder and Chief Product Officer, Opentrons; Douglas Densmore, Ph.D., Associate Professor, Department of Electrical and Computer Engineering, Boston University; James Inglese, Ph.D., Principal Investigator, Assay Development & Screening Technology, National Center for Advancing Translational Sciences, NIH, and Lenny Teytelman, Co-founder, Protocols.io.

More information about registration, a full speaker list, the agenda, sponsorship and more may be found at http://www.gbsi.org. Journalists may contact cmiller@gbsi.org.

Related Events

Comments